Newbury Pharmaceuticals AB (publ) (STO:NEWBRY)
Sweden · Delayed Price · Currency is SEK 2.400
-0.010 (-0.41%)
Sep 4, 2026, 12:49 PM CET
STO:NEWBRY Market Cap
STO:NEWBRY has a market cap or net worth of 72.95 million as of September 4, 2026. Its market cap has decreased by -3.23% in one year.
Market Cap
72.95M
Enterprise Value
58.28M
Revenue
35.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.40
ChartMarket Cap Chart
Since February 4, 2022, STO:NEWBRY's market cap has decreased from 245.97M to 72.95M, a decrease of -70.34%. That is a compound annual growth rate of -23.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 72.95M | 108.70% |
| Dec 30, 2025 | 34.96M | -59.06% |
| Dec 30, 2024 | 85.39M | 42.48% |
| Dec 29, 2023 | 59.93M | -56.08% |
| Dec 30, 2022 | 136.45M | -44.52% |
| Feb 4, 2022 | 245.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nanexa AB | 1.11B |
| Dicot Pharma AB | 881.74M |
| EQL Pharma AB | 782.53M |
| Cinclus Pharma Holding AB | 567.76M |
| Orexo AB | 537.79M |
| Moberg Pharma AB | 524.65M |
| Enzymatica AB | 490.32M |
| Klaria Pharma Holding AB (publ.) | 155.70M |